These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Estimation of uricosuric activity of sulfinpyrazone in healthy adults. Malamos B; Sfikakis P; Tsekos G; Tasiopoulos T Z Rheumaforsch; 1968 Apr; 27(3):125-8. PubMed ID: 5686580 [No Abstract] [Full Text] [Related]
29. [CASE OF CHRONIC TOPHOCEOUS GOUT]. ITO H; OKAZAKI M; AKAOKA I; KOYAMA S Iryo; 1963 Dec; 17():736-40. PubMed ID: 14123823 [No Abstract] [Full Text] [Related]
30. Pharmacology of uricosuric drugs. Kippen I; Whitehouse MW; Klinenberg JR Ann Rheum Dis; 1974 Jul; 33(4):391-6. PubMed ID: 4213293 [No Abstract] [Full Text] [Related]
31. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. BURNS JJ; YU TF; RITTERBAND A; PEREL JM; GUTMAN AB; BRODIE BB J Pharmacol Exp Ther; 1957 Mar; 119(3):418-26. PubMed ID: 13417097 [No Abstract] [Full Text] [Related]
32. Studies with some novel uricosuric agents and their metabolites: correlation between clinical activity and drug-induced displacement of urate from its albumin-binding sites. Schlosstein LH; Kippen I; Whitehouse MW; Bluestone R; Paulus HE; Klinenberg JR J Lab Clin Med; 1973 Sep; 82(3):412-8. PubMed ID: 4740876 [No Abstract] [Full Text] [Related]
33. Pharmacologic approach to the maintenance of urate homeostasis. Kelley WN Nephron; 1975; 14(1):99-115. PubMed ID: 1091870 [TBL] [Abstract][Full Text] [Related]
34. The treatment of hyperuricemia in gout. Rastegar A; Thier SO Ration Drug Ther; 1974 Mar; 8(3):1-4. PubMed ID: 4820829 [No Abstract] [Full Text] [Related]
35. Management of gout and hyperuricemia. Wisner DE; Simkin PA Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519 [TBL] [Abstract][Full Text] [Related]
36. [Gout (pathogenesis and therapy)]. Chirone E Policlinico Prat; 1968 Feb; 75(6):177-87. PubMed ID: 5744779 [No Abstract] [Full Text] [Related]
37. Management of gout. Scott JT Br Med J; 1969 Aug; 3(5668):456-7. PubMed ID: 5811656 [No Abstract] [Full Text] [Related]
38. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout]. Zöllner N; Griebsch A; Fink JK Dtsch Med Wochenschr; 1970 Nov; 95(48):2405-12. PubMed ID: 5480261 [No Abstract] [Full Text] [Related]
39. Hyperuricemia and gout. Classification, complications and management. Boss GR; Seegmiller JE N Engl J Med; 1979 Jun; 300(26):1459-68. PubMed ID: 221806 [No Abstract] [Full Text] [Related]
40. The treatment of hyperuricemia. Lowenthal DT Am Fam Physician; 1976 Jul; 14(1):98-100. PubMed ID: 937167 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]